Laboratory-developed test regulation and the immunocompromised patient: Uncertainty ahead

Keyphrases

• Immunocompromised Patients 100%
• Laboratory-developed Test 100%
• Regulatory Framework 100%
• Patient Uncertainty 100%
• Clinical Care 50%
• COVID-19 50%
• Deregulation 50%
• Regulatory Requirements 50%
• Statute 50%
• Moving Forward 50%
• In Vitro Diagnostics 50%
• U.S. Congress 50%
• Lawmakers 50%
• COVID-19 Response 50%
• Clinical Test Development 50%
• Market Review 50%

Nursing and Health Professions

• Severe Acute Respiratory Syndrome 100%
• Food and Drug Administration 100%
• Immunocompromised Patient 100%
• Diagnostic Test 100%
• COVID-19 100%

Medicine and Dentistry

• In Vitro 100%
• Immunocompromised Patient 100%
• Clinician 50%
• COVID-19 50%
• Severe Acute Respiratory Syndrome Coronavirus 2 50%
• Diagnostic Test 50%